image
Healthcare - Biotechnology - NASDAQ - US
$ 1.34
-2.9 %
$ 1.93 M
Market Cap
-0.15
P/E
CASH FLOW STATEMENT
-12.8 M OPERATING CASH FLOW
26.99%
0 INVESTING CASH FLOW
100.00%
6.64 M FINANCING CASH FLOW
234.09%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Salarius Pharmaceuticals, Inc.
image
Net Income -12.5 M
Depreciation & Amortization 10.1 K
Capital Expenditures -3
Stock-Based Compensation 525 K
Change in Working Capital -968 K
Others -63.3 K
Free Cash Flow -12.8 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
OPERATING CASH FLOW
Net Income (12.5) (31.6) (12.8) (7.4) (6.9) (21.9) (34.4) (39.5) (29.1) 0
Depreciation & Amortization 10.1 K 6.68 K 19.2 K 18.1 K 0.1 0.2 0.3 0.3 49.9 K 0
Deferred Income Tax 0 0 0 0 0 11.5 K 68.1 K 16.2 K 9.52 K 0
Stock Based Compensation 0.5 0.8 0.6 0.3 0.8 1.9 4.2 6.6 6.6 0
Other Operating Activities 0.1 10.8 44.7 K (0.3) (1.3) 20.3 K 1.78 K 3.43 K 4.12 K 0
Change in Working Capital (1.0) 2.4 2.0 (3.0) (4.2) (3.9) 2.2 0.6 1.7 0
Cash From Operations (12.8) (17.6) (10.2) (10.3) (11.6) (23.6) (27.7) (32.1) (20.7) 0
INVESTING CASH FLOW
Capital Expenditures 3 (1.5) 0 2.6 K 0 0 (0.1) (0.6) (0.3) 0
Other Items 3 0 0 0 5.6 14.1 24.6 (11.7) (27.0) 0
Cash From Investing Activities 0 (1.5) 0 2.6 K 5.6 14.1 24.5 (12.2) (27.3) 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid (0.3) 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 (0.1) 0 0 0 0 0
Other Financing Activities 0 0 28.3 17.7 (0.4) 0 0 0 0.4 0
Cash From Financing Activities 6.6 2.0 28.3 17.7 3.6 0.1 2.63 K 22.1 K 80.8 0
CHANGE IN CASH
Net Change In Cash (6.2) (17.1) 18.1 7.4 (2.4) (9.4) (3.2) (44.3) 32.8 0
FREE CASH FLOW
Free Cash Flow (12.8) (19.1) (10.2) (10.3) (11.6) (23.6) (27.8) (32.6) (21.0) 0